Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Issues in polypharmacotherapy: focus on major depression

¹University of Rhode Island College of Pharmacy, Providence, USA.

Psychopharmacology Bulletin

|January 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient compliance and blood pressure control on a nuclear-powered aircraft carrier: impact of a pharmacy officer.

Military medicine·2000

Same author

Elevated serum triglycerides with clozapine resolved with risperidone in four patients.

Pharmacotherapy·1999

Same author

Olanzapine increases weight and serum triglyceride levels.

The Journal of clinical psychiatry·1999

Same author

Clozapine-associated elevation in serum triglycerides.

The American journal of psychiatry·1999

Same author

Current knowledge of the cytochrome P-450 isozyme system: can we predict clinically important drug interactions?

Medicine and health, Rhode Island·1998

Same author

Serum triglyceride levels in patients treated with clozapine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996

Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026

Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026

Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026

Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026

Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026

Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026

See all related articles

Combination therapy, including lithium and triiodothyronine (T3), effectively treats major depressive disorders, especially treatment-resistant cases. Augmentation strategies can speed patient response to antidepressants.

Area of Science:

Psychiatry
Pharmacology
Neuroscience

Background:

Combination therapy is a common strategy in pharmacotherapy to enhance treatment efficacy.
Polypharmacotherapy is frequently employed for major depressive disorders (MDD).

Purpose of the Study:

To examine key issues concerning polypharmacotherapy in treating major depressive disorders.
To discuss established and novel combination strategies for MDD.

Main Methods:

Review of existing literature on combination pharmacotherapy for depression.
Analysis of augmentation strategies including lithium and triiodothyronine (T3).

Main Results:

Lithium and T3 are effective augmentation strategies for treatment-resistant depression.

Related Experiment Videos

Lithium augmentation of certain antidepressants and combined serotonergic/noradrenergic agents may hasten response.

Newer combination strategies for MDD are also considered.

Conclusions:

Combination therapy, particularly with agents like lithium, offers significant benefits in managing major depressive disorders.
Augmentation and combination strategies are crucial for improving treatment outcomes and response times in MDD.